Physician profile
Jonathan M Fialkov
NPI 1518951532
$1,503.75
in general payments reported to CMS, 2019-2025
15 companies · $517 in 2025
The $517 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $36.93 · 2022: $117 · 2023: $196 · 2024: $636 · 2025: $517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $745 · Education: $333 · Travel and Lodging: $272.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $744.82 |
| Education | $332.98 |
| Travel and Lodging | $271.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $503.27 | 2024-2025 | Aquabeam System |
| Astellas Pharma US INC | $411.98 | 2023-2025 | Xtandi |
| Pfizer INC. | $184.42 | 2022-2025 | |
| Coloplast Corp | $93.83 | 2021-2023 | Titan |
| Intuitive Surgical, INC. | $71.32 | 2025 | |
| Tolmar, INC. | $59.70 | 2023-2025 | Jatenzo, Eligard |
| Axonics, INC. | $36.05 | 2022-2023 | Bulkamid, Axonics |
| Medtronic, INC. | $28.04 | 2025 | Altaviva |
| Urogen Pharma, INC. | $23.02 | 2025 | |
| Innovation Technologies INC | $21.74 | 2025 | Irrisept |
| Boston Scientific Corporation | $20.27 | 2024 | Advance Xp |
| Ferring Pharmaceuticals INC. | $17.19 | 2025 | Adstiladrin |
| Bayer Healthcare Pharmaceuticals INC. | $16.80 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $16.12 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Fialkov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.